منابع مشابه
EVectiveness bulletin Drug treatments for schizophrenia
Background Schizophrenia is an illness or a group of illnesses aVecting language, planning, emotion, perceptions, and movement. In the UK, approximately 250 000 people suVer from schizophrenia or a schizophrenia-like illness. A quarter of those who have experienced an episode of schizophrenia recover and the illness does not recur. Another 25% experience an unremitting illness. The remaining 50...
متن کاملPsychosocial Treatments for Schizophrenia
This article focuses on the importance of psychosocial interventions for individuals with schizophrenia. We present recent research in the areas of cognitive behavior therapy, social skills training, family interventions, supported employment, and cognitive remediation. We consider issues within those domains of treatment, such as symptom remission versus functional recovery, the limitations of...
متن کامل[Efficacy of integrated treatments for schizophrenia patients].
This article outlines two examples of cognitive-behavior group therapy approaches for an integrative treatment of psychosis: the Integrated Psychological Therapy (IPT) and the Integrated Neurocognitive Therapy (INT). We present their theoretical background, content and conceptualization as well as recent empirical evidence for their efficacy. The article concludes that adapting these approaches...
متن کاملNew drug treatments for epilepsy
After the introduction of valproate in 1973, excluding benzodiazepines, there was a 19 year gap before the introduction of vigabatrin, the first in a series of new antiepileptic drugs to be developed and licensed. At the time of writing gabapentin, lamotrigine, oxcarbazepine, tiagabine, and topiramate have a licence in the United Kingdom. Zonisamide and levetiracetam are licensed in some countr...
متن کاملDrug treatments for Alzheimer's disease.
This article discusses the development and progress of treatment for Alzheimer's disease. Medical treatments have not changed since the late 1990s and have limited effects. They treat the symptoms patients experience but do not reverse the effects or repair neurological damage caused by Alzheimer's disease. Updated NICE guidance and likely future advances in treatment are also
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Quality in Health Care
سال: 2000
ISSN: 0963-8172
DOI: 10.1136/qhc.9.1.73